Juvenile Diabetes Cure Alliance Hires Former Wall Street Equity Analyst as Director of Research Analysis

Diabetes charity watchdog organization welcomes Aaron Gorin, seasoned healthcare and diabetes researcher

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This

New York, NY (PRWEB) October 14, 2013

The independent, nonprofit Juvenile Diabetes Cure Alliance today announced the appointment of Aaron Gorin as director of research analysis. Gorin will use his for-profit experience in researching the practices and outcomes of the four primary diabetes nonprofits identified by the JDCA.

As an equity analyst at Morgan Stanley, Merrill Lynch and Bank of America, Gorin specialized in Biotech, Pharmaceutical, and Healthcare Services corporate research. As director of research analysis at the JDCA, he will employ his Wall Street background to delve into current state of diabetes funding and illustrate the need for reform.

“As the only organization attempting to increase diabetes nonprofit accountability, the JDCA is looking forward to the level of expertise and intellect Aaron will bring to the team,” said Phil Shaw, general manager of the JDCA. “His background and interest in diabetes cure research will position the JDCA to continue providing well-informed analysis about type 1 charitable foundations.”

Gorin will take an analytical and business-like approach to researching organizations like the American Diabetes Association, Diabetes Research Institute Foundation, JDRF and Joslin Diabetes Center. In uncovering information either inaccessible to or difficult to obtain for the general public, he’ll concentrate on diabetes nonprofit executive compensation, funding priorities and corporate governance practices.

“The JDCA is committed to the singular focus of bringing about a practical cure by 2025. The facts surrounding diabetes research are eye-opening, even for the occasional donor,” said Gorin. “Cure research is poorly prioritized yet costly and unfortunately, no real progress towards a cure is actually being made.”

Along with his experiences in type 1 research and Wall Street background in healthcare financial analysis, Gorin plans to use his new role as a platform to provide data-driven conclusions about the true progress towards a cure to advocates and shareholders. He holds a bachelor’s degree in economics and a master’s in health administration from Cornell University.

About the JDCA

The JDCA is an independent analyst of the type 1 diabetes charitable universe and brings a business-like perspective to help donors focus research toward a practical cure. The mission of the JDCA is to achieve a type 1 practical cure before 2025 by steering donor contributions to the most effective charities.

Become an Alliance member:http://bit.ly/JointheJDCA
Become a fan on Facebook: https://www.facebook.com/thejdca
Follow us on Twitter: http:// https://twitter.com/JDCA2025


Contact

  • Kikora Mason
    Walker Sands Communications
    +1 (312) 648-6009
    Email